However, if we define the clinically important threshold of AAT as the upper limit of intermediate AAT deficiency, which has been recently suggested as 0.92 g/L [20], we have more than 99.9% power to detect such a large-impact variant. Here, SERPINA1 is linked to alpha 1-antitrypsin deficiency.